|
IMPORTANT NOTE: ZOCOR is a prescription
tablet and isn’t right for everyone, including women
who are nursing or pregnant or who may become pregnant,
and anyone with liver problems. Unexplained muscle pain
or weakness could be a sign of a rare but serious side
effect and should be reported to your doctor right away.
ZOCOR may interact with other medicines or certain foods,
increasing your risk of getting this serious side effect.
So tell your doctor about any other medications you are
taking.
ZOCOR SIMVASTATIN - ORAL
COMMON BRAND NAME(S): Zocor® - Zocor (Simvastatin)
USES: Zocor (Simvastatin) is used to treat help
lower cholesteral.
HOW TO USE:
- Take Zocor (Simvastatin) tablets by
mouth.
- Follow the directions on the Zocor (Simvastatin)
prescription label.
- Swallow
the Zocor (Simvastatin) with a drink of water.
- Take your Zocor (Simvastatin) doses at regular intervals.
- Do not
take Zocor (Simvastatin) more often than directed.
Atorvastatin, cerivastatin, fluvastatin, lovastatin, pravastatin,
and simvastatin are used to lower levels of cholesterol and
other fats in the blood. This may help prevent medical problems
caused by cholesterol clogging the blood vessels.
These medicines belong to the group of medicines called
3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase
inhibitors. They work by blocking an enzyme that is needed
by the body to make cholesterol. Thus, less cholesterol is
made.
HMG-CoA reductase inhibitors are available only with your
doctor's prescription, in the following dosage forms:
Oral
- Atorvastatin
- Tablets (U.S. and Canada)
- Cerivastatin
- Fluvastatin
- Capsules (U.S. and Canada)
- Lovastatin
- Extended-Release Tablets (U.S.)
- Tablets (U.S. and Canada)
- Pravastatin
- Tablets (U.S. and Canada)
- Simvastatin
- Tablets (U.S. and Canada)
In deciding to use a medicine, the risks of taking the medicine
must be weighed against the good it will do. This is a decision
you and your doctor will make. For HMG-CoA reductase inhibitors,
the following should be considered:
Allergies— Tell your doctor if you have ever had any unusual
or allergic reaction to HMG-CoA reductase inhibitors. Also
tell your health care professional if you are allergic to
any other substances, such as foods, preservatives, or dyes.
Diet— Before prescribing medicines to lower your cholesterol,
your doctor will probably try to control your condition by
prescribing a personal diet for you. Such a diet will be
lower in total fat, particularly saturated fat, and dietary
cholesterol. Many people are able to control their condition
by carefully following their doctor's orders for proper diet
and exercise. Medicine is prescribed only when additional
help is needed and is effective only when a schedule of diet
and exercise is properly followed.
Also, this medicine is less effective if you are greatly
overweight. It may be very important for you to go on a reducing
diet. However, check with your doctor before going on any
diet.
Pregnancy— HMG-CoA reductase inhibitors should not be used
during pregnancy or by women who plan to become pregnant
in the near future. These medicines block formation of cholesterol,
which is necessary for the fetus to develop properly. HMG-CoA
reductase inhibitors may cause birth defects or other problems
in the baby if taken during pregnancy. An effective form
of birth control should be used during treatment with these
medicines. Check with your doctor immediately if you think
you have become pregnant while taking this medicine . Be
sure you have discussed this with your doctor.
Breast-feeding— These medicines are not recommended for
use during breast-feeding because they may cause unwanted
effects in nursing babies.
Children— Studies on this medicine have been done only in
adult patients, and there is no specific information comparing
use of HMG-CoA reductase inhibitors in children with use
in other age groups. However, atorvastatin, lovastatin, and
simvastatin have been used in a limited number of children
under 18 years of age. Early information seems to show that
these medicines may be effective in children, but their long-term
safety has not been studied.
Older adults— This medicine has been tested in a limited
number of patients 65 years of age or older and has not been
shown to cause different side effects or problems in older
people than it does in younger adults.
Other medicines— Although certain medicines should not be
used together at all, in other cases two different medicines
may be used together even if an interaction might occur.
In these cases, your doctor may want to change the dose,
or other precautions may be necessary. When you are taking
HMG-CoA reductase inhibitors, it is especially important
that your health care professional know if you are taking
any of the following:
- Cyclosporine (e.g., Sandimmune) or
- Gemfibrozil (e.g., Lopid) or
- Clofibrate (e.g., Atromid-S) or
- Fenofibrate (e.g., Tricor) or
- Niacin—Use of these medicines with an HMG-CoA reductase
inhibitor may increase the risk of developing muscle problems
and kidney failure
- Digoxin (e.g., Lanoxin)—Use with atorvastatin, fluvastatin,
or simvastatin may increase blood levels of digoxin, increasing
the risk of side effects
- Oral contraceptives, (birth control tablets)—Atorvastatin
may increase the blood levels of the birth control hormones,
increasing the risk of side effects
- HIV protease inhibitors (Amprenavir [e.g., Agenerase],
Indinavir [e.g., Crixivan], Nelfinavir [e.g., Viracept],
Ritonavir [e.g., Norvir], Saquinavir [e.g., Fortovase,
Invirase]) or
- Nefazodone (e.g. Serzone)—Use with simvastatin may increase
the risk of developing muscle problems and kidney failure
- Verapamil (e.g. Calan, Isoptin)—Use with simvastatin
may increase the risk of muscle problems
Other medical problems— The presence of other medical problems
may affect the use of HMG-CoA reductase inhibitors. Make sure
you tell your doctor if you have any other medical problems,
especially:
- Alcohol abuse (or history of) or
- Liver disease—Use of this medicine may make liver problems
worse
- Convulsions (seizures), not well-controlled, or
- Organ transplant with therapy to prevent transplant rejection
or
- If you have recently had major surgery—Patients with
these conditions may be at risk of developing problems
that may lead to kidney failure
|